Literature DB >> 35693082

A novel preoperative MRI-based radiomics nomogram outperforms traditional models for prognostic prediction in pancreatic ductal adenocarcinoma.

Hui Qiu1,2, Muchen Xu3, Yan Wang2, Xin Wen1,2, Xueting Chen2, Wanming Liu2, Nie Zhang2, Xin Ding1,2, Longzhen Zhang1,2.   

Abstract

To develop an efficient prognostic model based on preoperative magnetic resonance imaging (MRI) radiomics for patients with pancreatic ductal adenocarcinoma (PDAC), the preoperative MRI data of PDAC patients in two independent centers (defined as development cohort and validation cohort, respectively) were collected retrospectively, and the radiomics features of tumors were then extracted. Based on the optimal radiomics features which were significantly related to overall survival (OS) and progression-free survival (PFS), the score of radiomics signature (Rad-score) was calculated, and its predictive efficiency was evaluated according to the area under receiver operator characteristic curve (AUC). Subsequently, the clinical-radiomics nomogram which incorporated the Rad-score and clinical parameters was developed, and its discrimination, consistency and application value were tested by calibration curve, concordance index (C-index) and decision curve analysis (DCA). Moreover, the predictive value of the clinical-radiomics nomogram was compared with traditional prognostic models. A total of 196 eligible PDAC patients were enrolled in this study. The AUC value of Rad-score for OS and PFS in development cohort was 0.724 and 0.781, respectively, and the value of Rad-score was negatively correlated with PDAC's prognosis. Moreover, the developed clinical-radiomics nomogram showed great consistency with the C-index for OS and PFS in development cohort was 0.814 and 0.767, respectively. In addition, the DCA demonstrated that the developed nomogram displayed better clinical predictive usefulness than traditional prognostic models. We concluded that the preoperative MRI-based radiomics signature was significantly related to the poor prognosis of PDAC patients, and the developed clinical-radiomics nomogram showed better predictive ability, it might be used for individualized prognostic assessment of preoperative patients with PDAC. AJCR
Copyright © 2022.

Entities:  

Keywords:  Pancreatic ductal adenocarcinoma; nomogram; prognostic model; radiomics

Year:  2022        PMID: 35693082      PMCID: PMC9185614     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   5.942


  34 in total

1.  Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  M Ducreux; A Sa Cuhna; C Caramella; A Hollebecque; P Burtin; D Goéré; T Seufferlein; K Haustermans; J L Van Laethem; T Conroy; D Arnold
Journal:  Ann Oncol       Date:  2015-09       Impact factor: 32.976

2.  Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection.

Authors:  Tiansong Xie; Xuanyi Wang; Menglei Li; Tong Tong; Xiaoli Yu; Zhengrong Zhou
Journal:  Eur Radiol       Date:  2020-01-31       Impact factor: 5.315

3.  Pancreatic Adenocarcinoma, Version 1.2019.

Authors:  Margaret A Tempero; Mokenge P Malafa; E Gabriela Chiorean; Brian Czito; Courtney Scaife; Amol K Narang; Christos Fountzilas; Brian M Wolpin; Mahmoud Al-Hawary; Horacio Asbun; Stephen W Behrman; Al B Benson; Ellen Binder; Dana B Cardin; Charles Cha; Vincent Chung; Mary Dillhoff; Efrat Dotan; Cristina R Ferrone; George Fisher; Jeffrey Hardacre; William G Hawkins; Andrew H Ko; Noelle LoConte; Andrew M Lowy; Cassadie Moravek; Eric K Nakakura; Eileen M O'Reilly; Jorge Obando; Sushanth Reddy; Sarah Thayer; Robert A Wolff; Jennifer L Burns; Griselda Zuccarino-Catania
Journal:  J Natl Compr Canc Netw       Date:  2019-03-01       Impact factor: 11.908

4.  Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations.

Authors:  Lei Huang; Lina Jansen; Yesilda Balavarca; Esther Molina-Montes; Masoud Babaei; Lydia van der Geest; Valery Lemmens; Liesbet Van Eycken; Harlinde De Schutter; Tom B Johannesen; Claus W Fristrup; Michael B Mortensen; Maja Primic-Žakelj; Vesna Zadnik; Nikolaus Becker; Thilo Hackert; Margit Mägi; Tiziana Cassetti; Romano Sassatelli; Robert Grützmann; Susanne Merkel; Ana F Gonçalves; Maria J Bento; Péter Hegyi; Gábor Lakatos; Andrea Szentesi; Michel Moreau; Tony van de Velde; Annegien Broeks; Milena Sant; Pamela Minicozzi; Vincenzo Mazzaferro; Francisco X Real; Alfredo Carrato; Xavier Molero; Marc G Besselink; Núria Malats; Markus W Büchler; Petra Schrotz-King; Hermann Brenner
Journal:  Gut       Date:  2017-11-20       Impact factor: 23.059

5.  Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features.

Authors:  Francesco Puleo; Rémy Nicolle; Yuna Blum; Jérôme Cros; Laetitia Marisa; Pieter Demetter; Eric Quertinmont; Magali Svrcek; Nabila Elarouci; Juan Iovanna; Denis Franchimont; Laurine Verset; Maria Gomez Galdon; Jacques Devière; Aurélien de Reyniès; Pierre Laurent-Puig; Jean-Luc Van Laethem; Jean-Baptiste Bachet; Raphaël Maréchal
Journal:  Gastroenterology       Date:  2018-08-27       Impact factor: 22.682

6.  Overview of radiomics in breast cancer diagnosis and prognostication.

Authors:  Alberto Stefano Tagliafico; Michele Piana; Daniela Schenone; Rita Lai; Anna Maria Massone; Nehmat Houssami
Journal:  Breast       Date:  2019-11-06       Impact factor: 4.380

7.  Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma.

Authors:  Farzad Khalvati; Yucheng Zhang; Sameer Baig; Edrise M Lobo-Mueller; Paul Karanicolas; Steven Gallinger; Masoom A Haider
Journal:  Sci Rep       Date:  2019-04-01       Impact factor: 4.379

8.  Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center analysis.

Authors:  Hao Hu; Chang Qu; Bingjun Tang; Weikang Liu; Yongsu Ma; Yiran Chen; Xuehai Xie; Yan Zhuang; Hongqiao Gao; Xiaodong Tian; Yinmo Yang
Journal:  Chin J Cancer Res       Date:  2021-08-31       Impact factor: 5.087

9.  Real-world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinoma.

Authors:  Kenneth H Yu; Muhammet Ozer; Paul Cockrum; Andy Surinach; Shu Wang; Bong Chul Chu
Journal:  Cancer Med       Date:  2021-11-22       Impact factor: 4.452

10.  Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer.

Authors:  Yuming Jiang; Chuanli Chen; Jingjing Xie; Wei Wang; Xuefan Zha; Wenbing Lv; Hao Chen; Yanfeng Hu; Tuanjie Li; Jiang Yu; Zhiwei Zhou; Yikai Xu; Guoxin Li
Journal:  EBioMedicine       Date:  2018-09-14       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.